SCHEDULE 13G

BIOXCEL THERAPEUTICS INC

Common Stock, par value $0.001 per share · CUSIP: 09075P204

Event date: 2025-09-29

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Integrated Core Strategies (US) LLC

  Shares: 1,026,054.00 · Class: 5.2%

• Millennium Management LLC

  Shares: 1,028,053.00 · Class: 5.2%

• Millennium Group Management LLC

  Shares: 1,028,053.00 · Class: 5.2%

• Israel A. Englander

  Shares: 1,028,053.00 · Class: 5.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.